Latest Features

more features >>

Latest Patient Perspectives


Rare Care Podcast

Browse Rare Disease Advisor’s engaging “Rare Care” podcast series, featuring interviews with leading researchers, stakeholders, and influencers within the rare disease community.


Latest HCP Insights

Lung Transplantation for IPF: Risk Factors and Complications

In severe cases of idiopathic pulmonary fibrosis (IPF), lung transplantation may be offered. However, lung transplantation is a major surgery in which many complications may develop. The greatest danger is, of course, death. Therefore, it is important that we give due weight to the risk factors associated with higher frequencies of post-transplant complications, as well…

IPF therapies

The Role of Medical Imaging in Alpha-1 Antitrypsin Deficiency

It is difficult for modern physicians to imagine medicine without the convenience of medical imaging. When I worked as a junior doctor in Borneo, the older doctors were clearly much better at bedside diagnoses than us younger ones. What could be the reason for this? One possible explanation was the relative scarcity of imaging modalities…

MTC prognosis

Challenges in Diagnostic Imaging of Medullary Thyroid Carcinoma

Thyroid ultrasound is the gold-standard diagnostic tool to identify thyroid nodules at the highest risk for malignancy. However, it lacks the specificity to accurately detect medullary thyroid carcinoma (MTC), thereby delaying treatment initiation. According to the available data, thyroid ultrasound can identify a malignant lesion in the correct thyroid lobe with a 90% sensitivity, but…

Exploring Right Ventricular Failure in Pulmonary Arterial Hypertension

Every year, the American Thoracic Society (ATS) organizes a conference in which ideas are exchanged and the latest research developments in the field of respiratory medicine are presented. Despite coronavirus disease 2019 (COVID-19) restrictions, the 2020 conference went ahead virtually and was, by all accounts, a major success.  Medical conferences such as these, besides allowing…

Improvements in the Clinical Management of Advanced GIST

The clinical management of metastatic gastrointestinal stromal tumor (GIST) has greatly improved since the early 2000s. The approval of imatinib mesylate (Gleevec®) in 2002 by the US Food and Drug Administration (FDA) was a major turning point in the survival of patients with GIST. Since then, as mentioned by Drs. Patel and Reichardt, "a treatment…


Meeting Coverage